The Medical-Industrial Complex

>Three years ago, the Department of Justice took stock of the orthopedic medical device industry--represented by the five big makers of orthopedic implants--and concluded that it was rampantly violating federal anti-kickback laws with the bribes and favors it was offering to surgeons. Such bribes often came in the form of training grants for those just starting out in the profession, or as lucrative consulting contracts for influential academic orthopedists.

The Justice Department fined the companies $311 million, and imposed mandatory new corporate compliance measures. But while the companies did modify some of their methods in accordance with new, more stringent oversight, they have nonetheless continued to funnel large sums toward the training of orthopedic surgeons who are in a position to use and promote their products. Indeed, crosschecking 2010 grant reports from two orthopedic foundations (Orthopaedic Research and Education Foundation and OMeGA Medical Grants Association) against the roster of training programs published annually by the American Academy of Orthopedic Surgeons reveals that the industry is subsidizing the salaries of up to one-fourth of 2010's approximately six hundred new orthopedists at medical centers across the country, as they learn how to use these companies' latest products.

"If you fund a pipeline of people that are going to be the users of the product, then that's the way you keep getting the product to be sold," explains Dr. Charles Rosen, the only orthopedist who testified before the Senate's Special Committee on Aging in support of the Physician Payments Sunshine Act, a mandate requiring corporations to make the consulting contracts and gifts they disburse public.

The Sunshine Act finally made its way into law this March as part of the health care reform bill. But so far, it, like the Department of Justice ruling, has done little to change the way orthopedics operates. Money continues to flow at a growing rate from industry to trainees. The difference now is that companies no longer give the money directly to specific surgeons, instead depositing it with third-party foundations, like the Orthopaedic Medical Grants Association (OMeGA) and the Orthopaedic Research and Education Foundation (OREF), who then pass it along to orthopedic departments. The new method is designed to prevent companies from rewarding specific surgeons for using their products. As Dr. Frank B. Kelly, chairman of OREF's Education Grants Board explains, "we...make sure that the money is disbursed in a random and nonbiased fashion in compliance with the DOJ." Any program that meets standards specified by the Accreditation Council for Graduate Medical Education can enter the funding lottery.

But despite these new controls, the device industry still can - and does--earmark its donations for certain types of orthopedic subspecialties over others, thereby creating external incentives and pressures that influence the field to the detriment of patients.

* * * * * *

Take orthopedic back treatment, a magnet for device industry dollars.

Age-related back problems that were once commonly treated by simply cutting out small pieces of bone or fusing just two vertebrae together, are increasingly treated by fusing several vertebrae together from multiple sides. The newer methods are more costly to Medicare, risk more dangerous complications, and yield no better results, as a major study reported in April. But these more complex procedures--which translate into higher reimbursements for surgeons and equipment-makers - are rising in popularity.

In many cases, surgeries are being performed even when arguably no intervention at all is warranted. At a 2009 national orthopedics conference in Bonita Springs, Florida, the usefulness of surgery for back pain was debated. Those arguing against surgery pointed out that while 85 percent of adults experience lower back pain at some point in their lives, for all but 10 percent, the pain goes away within three months, regardless of what doctors do. In a poll that followed the debate, only one member in attendance volunteered that if she had "discogenic" back pain, she would choose surgery.

Yet surgeons fuse backs for lower back pain more often than for any other malady. Indeed, between 1998 and 2004, the amount spent on back surgery tripled from under six billion to $17.6 billion dollars per year. In most cases, it's the appearance of a dark-looking "degenerated" disc on an MRI scan that precipitates a doctor's decision to perform lower back surgery. But the appearance of such darkened disks are so common in people even without pain, that it's essentially meaningless.

It's worth noting that most orthopedic spine surgery programs can credit a piece of their financial security this year to donations from the companies that make spine implant and spine fusion equipment. Depuy Spine, Inc., alone allocated $2 million to pay for 25 new spine surgeons to start training in July. "There is too much surgery being done and industry is facilitating it," says Dr. Rosen, "because they're creating the demand by sponsoring fellowships." Indeed, as industry-sponsored fellowship programs turn out more and more doctors trained to perform these kinds of complex back fusions, the pressure grows on those doctors to find more patients to undergo such procedures - whether it's the best treatment option for them or not.

The device industry's second favorite orthopedic specialty, by giving, is hip and knee replacement. There again, industry underwrites the majority of the formal training programs in this country (benefactors include all five of the DOJ-targeted companies). By contrast, such subspecialties as orthopedic cancer surgery and orthopedics for children share just six funded fellowships between them.

And forget about nonsurgical training. Dr. Eric Campbell, research director at the Mongan Institute for Health Policy, says he'll curb his skepticism about industry manipulation of the field on the day that device manufacturers decide to fund fellowships at five major universities using nonoperative approaches to managing chronic back pain.

* * * * * *

In these ways, industry-salaried training promotes treatments designed to earn the sponsoring companies the most money - not necessarily the treatments that are in fact the most important or beneficial. So far, however, professional organizations have given the issue little attention. Defending the continued flow of industry money into the field, a board member of OREF points out that while institutions like Massachusetts General Hospital, Johns Hopkins and the Mayo Clinic might be able to offer their usual roster of fellowships without the company checks they're depositing this year, lower profile, less well endowed institutions might not.

Presented by

Ford Vox, MD, is a physician, based in Atlanta, who specializes in caring for people with complex brain injuries. He has written for Newsweek, Slate, and the Los Angeles Times.

How to Cook Spaghetti Squash (and Why)

Cooking for yourself is one of the surest ways to eat well. Bestselling author Mark Bittman teaches James Hamblin the recipe that everyone is Googling.

Join the Discussion

After you comment, click Post. If you’re not already logged in you will be asked to log in or register.

blog comments powered by Disqus


How to Cook Spaghetti Squash (and Why)

Cooking for yourself is one of the surest ways to eat well.


Before Tinder, a Tree

Looking for your soulmate? Write a letter to the "Bridegroom's Oak" in Germany.


The Health Benefits of Going Outside

People spend too much time indoors. One solution: ecotherapy.


Where High Tech Meets the 1950s

Why did Green Bank, West Virginia, ban wireless signals? For science.


Yes, Quidditch Is Real

How J.K. Rowling's magical sport spread from Hogwarts to college campuses


Would You Live in a Treehouse?

A treehouse can be an ideal office space, vacation rental, and way of reconnecting with your youth.

More in Technology

Just In